Clinical characteristics of the ALK fusion-positive bladder PMP and efficacy of lorlatinib: a two-case report and literature review. Sun M, Ju M, Zhang H, Huang N, et al. Oncologist 2025;30:oyaf389.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sun M, Ju M, Zhang H, Huang N, et al. Clinical characteristics of the ALK fusion-positive bladder PMP and efficacy of lorlatinib: a two-case report and literature review. Oncologist 2025;30:oyaf389.
PMID: 41273779